| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.38B | +30.3% |
| Cost of Revenue | $212.7M | +31.4% |
| R&D Expense | $148.3M | +25.3% |
| SG&A Expense | $783.8M | +22.5% |
| Operating Income | $378.7M | +49.3% |
| Interest Expense | $2.5M | +81.1% |
| Pre-tax Income | $389.6M | +52.2% |
| Income Tax | $108.2M | +80.3% |
| Net Income | $281.4M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $400.7M | +44.2% |
| Accounts Receivable | $22.8M | +140.7% |
| Inventory | $1.6M | +42.1% |
| Current Assets | $2.76B | +22.7% |
| Total Assets | $3.90B | +21.4% |
| Current Liabilities | $2.38B | +19.4% |
| Long-term Debt | $29.0M | -0.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $365.1M | +14.3% |
| Capital Expenditures | $132.7M | +9.9% |
| Investing Cash Flow | -$23.3M | +91.0% |
| Financing Cash Flow | $254.6M | +53.6% |
| Free Cash Flow | $232.4M | +17.0% |
| +43.6% |
| EPS (Basic) | $4.86 | +43.4% |
| EPS (Diluted) | $4.84 | +43.6% |
| Total Liabilities |
| $2.72B |
| +17.2% |
| Stockholders' Equity | $1.18B | +32.3% |